Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Robert C. Owens"'
Autor:
Sujata M. Bhavnani, Catharine C. Bulik, Elizabeth A Lakota, Robert C. Owens, Paul G. Ambrose, Christopher M. Rubino, Kim L Sweeney, Justin C Bader
Publikováno v:
Open Forum Infectious Diseases
Background The importance of delivering appropriate therapy to patients at the onset of treatment is well established. However, this goal is easier said than done given the complexity and uniqueness of each patient case. Nonetheless, treatment decisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9da4d864c884ed61f826ec46295be107
http://europepmc.org/articles/PMC5631755
http://europepmc.org/articles/PMC5631755
Publikováno v:
Pharmacotherapy. 29:593-607
In 2007, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America published a document that addressed the major considerations for the justification, description, and conduct of antimicrobial stewardship progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c01e3ce25be696b318734a8036f4f94
https://doi.org/10.1592/phco.29.5.593
https://doi.org/10.1592/phco.29.5.593
Autor:
Robert C. Owens
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 61:110-128
Large worldwide surveillance studies report that resistance to nearly all classes of antimicrobial is increasing, as is the emergence of what have been termed pan-drug-resistant and extremely drug-resistant pathogens. Concomitantly, bacterial binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38c806541c3d978ac466c4d97b917f4b
https://doi.org/10.1016/j.diagmicrobio.2008.02.012
https://doi.org/10.1016/j.diagmicrobio.2008.02.012
Publikováno v:
Clinical Infectious Diseases. 46:S19-S31
Antimicrobial therapy plays a central role in the pathogenesis of Clostridium difficile infection (CDI), presumably through disruption of indigenous intestinal microflora, thereby allowing C. difficile to grow and produce toxin. Investigations involv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1b49de1d0c3e677a2d786f04f7233d
https://doi.org/10.1086/521859
https://doi.org/10.1086/521859
Publikováno v:
The American Journal of Medicine. 120:S6-S12
A registry describing daptomycin's clinical use was analyzed to describe treatment of skin and skin-structure infections (SSSIs). The Cubicin Outcomes Registry and Experience (CORE) 2004 retrospectively collected demographic, microbiologic, and clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c43045895b31260882f252fd540cb15
https://doi.org/10.1016/j.amjmed.2007.07.009
https://doi.org/10.1016/j.amjmed.2007.07.009
Autor:
August J. Valenti, Robert C. Owens
Publikováno v:
Infectious Diseases in Clinical Practice. 15:299-315
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c17e32e065ebb6f65b556e7162143e75
https://doi.org/10.1097/ipc.0b013e3180686491
https://doi.org/10.1097/ipc.0b013e3180686491
Autor:
Simon D. Baines, Katie Saxton, Jane Freeman, Keith Stephenson, Robert C. Owens, Warren N. Fawley, Mark H. Wilcox, Sarah Underwood
Publikováno v:
Infection Control & Hospital Epidemiology. 28:920-925
Objective.To compare the effects of hospital cleaning agents and germicides on the survival of epidemicClostridium difficilestrains.Methods.We compared the activity of and effects of exposure to 5 cleaning agents and/or germicides (3 containing chlor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e097e6fda5602a4588958891226b8136
https://doi.org/10.1086/519201
https://doi.org/10.1086/519201
Autor:
Robert C. Owens
Publikováno v:
Drugs. 67:487-502
Clostridium difficile-associated disease (CDAD) is increasingly being reported in many regions throughout the world. The reasons for this are unknown, are likely to be multifactorial, and are the subject of several current investigations. In addition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821bed906efcc5e88b245856e35cbac0
https://doi.org/10.2165/00003495-200767040-00001
https://doi.org/10.2165/00003495-200767040-00001
Publikováno v:
Clinical Drug Investigation
Dalbavancin is a novel, once-weekly glycopeptide antibiotic approved for treatment of acute bacterial skin infections. Given the importance of understanding any pharmacokinetic variability across different patient populations, a double-blind, placebo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91efe453c508926292173077266e50c
https://pubmed.ncbi.nlm.nih.gov/26458939
https://pubmed.ncbi.nlm.nih.gov/26458939
Autor:
Robert C. Owens, Shannon H. Goldwater, Haiyuan Zhu, Edward Stenehjem, Yan Zong, Jack Brown, Patrick Scoble
Publikováno v:
Open Forum Infectious Diseases. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d21eb172a696692d005eddd54ac147cb
https://doi.org/10.1093/ofid/ofv133.1090
https://doi.org/10.1093/ofid/ofv133.1090